These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 23785043

  • 1. Effects of chitosan on plasma lipids and lipoproteins: a 4-month prospective pilot study.
    Rizzo M, Giglio RV, Nikolic D, Patti AM, Campanella C, Cocchi M, Katsiki N, Montalto G.
    Angiology; 2014 Jul; 65(6):538-42. PubMed ID: 23785043
    [Abstract] [Full Text] [Related]

  • 2. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
    Mackness MI, Bhatnagar D, Durrington PN, Prais H, Haynes B, Morgan J, Borthwick L.
    Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
    [Abstract] [Full Text] [Related]

  • 3. Effects of increasing doses of atorvastatin on the atherogenic lipid subclasses commonly associated with hypertriglyceridemia.
    Karalis DG, Ishisaka DY, Luo D, Ntanios F, Wun CC.
    Am J Cardiol; 2007 Aug 01; 100(3):445-9. PubMed ID: 17659926
    [Abstract] [Full Text] [Related]

  • 4. Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: effect of triglyceride reductions with atorvastatin.
    Le NA, Innis-Whitehouse W, Li X, Bakker-Arkema R, Black D, Brown WV.
    Metabolism; 2000 Feb 01; 49(2):167-77. PubMed ID: 10690940
    [Abstract] [Full Text] [Related]

  • 5. Low-density lipoprotein particle size, triglyceride-rich lipoproteins, and glucose tolerance in non-diabetic men with essential hypertension.
    Rubies-Prat J, Ordóñez-Llanos J, Martin S, Blanco-Vaca F, Molina L, Goday A, Pedro-Botet J.
    Clin Exp Hypertens; 2001 Aug 01; 23(6):489-500. PubMed ID: 11478431
    [Abstract] [Full Text] [Related]

  • 6. Effect of atorvastatin on lipid parameters, LDL subtype distribution, hemorrheological parameters and adhesion molecule concentrations in patients with hypertriglyceridemia.
    Empen K, Geiss HC, Lehrke M, Otto C, Schwandt P, Parhofer KG.
    Nutr Metab Cardiovasc Dis; 2003 Apr 01; 13(2):87-92. PubMed ID: 12929621
    [Abstract] [Full Text] [Related]

  • 7. Hypertriglyceridemia during late pregnancy is associated with the formation of small dense low-density lipoproteins and the presence of large buoyant high-density lipoproteins.
    Silliman K, Shore V, Forte TM.
    Metabolism; 1994 Aug 01; 43(8):1035-41. PubMed ID: 8052144
    [Abstract] [Full Text] [Related]

  • 8. Distribution of lipoproteins triglyceride and lipoprotein cholesterol in an adult population by age, sex, and hormone use- The Pacific Northwest Bell Telephone Company health survey.
    Wahl PW, Warnick GR, Albers JJ, Hoover JJ, Walden CE, Bergelin RO, Ogilvie JT, Hazzard WR, Knopp RH.
    Atherosclerosis; 1981 Apr 01; 39(1):111-24. PubMed ID: 6941788
    [Abstract] [Full Text] [Related]

  • 9. Is directly measured low-density lipoprotein clinically equivalent to calculated low-density lipoprotein?
    Baruch L, Agarwal S, Gupta B, Haynos A, Johnson S, Kelly-Johnson K, Eng C.
    J Clin Lipidol; 2010 Apr 01; 4(4):259-64. PubMed ID: 21122658
    [Abstract] [Full Text] [Related]

  • 10. Effects of bezafibrate on lipoprotein subclasses and inflammatory markers in patients with hypertriglyceridemia--a nuclear magnetic resonance study.
    Ikewaki K, Noma K, Tohyama J, Kido T, Mochizuki S.
    Int J Cardiol; 2005 Jun 08; 101(3):441-7. PubMed ID: 15907413
    [Abstract] [Full Text] [Related]

  • 11. Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclasses in patients with growth hormone deficiency before and after short-term replacement therapy.
    Rizzo M, Trepp R, Berneis K, Christ ER.
    Eur J Endocrinol; 2007 Mar 08; 156(3):361-7. PubMed ID: 17322496
    [Abstract] [Full Text] [Related]

  • 12. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC.
    Pharmacotherapy; 1995 Mar 08; 15(3):317-37. PubMed ID: 7667166
    [Abstract] [Full Text] [Related]

  • 13. Effect of ezetimibe on low- and high-density lipoprotein subclasses in sitosterolemia.
    Othman RA, Myrie SB, Mymin D, Roullet JB, Steiner RD, Jones PJH.
    Atherosclerosis; 2017 May 08; 260():27-33. PubMed ID: 28340366
    [Abstract] [Full Text] [Related]

  • 14. Relationship of baseline HDL subclasses, small dense LDL and LDL triglyceride to cardiovascular events in the AIM-HIGH clinical trial.
    Albers JJ, Slee A, Fleg JL, O'Brien KD, Marcovina SM.
    Atherosclerosis; 2016 Aug 08; 251():454-459. PubMed ID: 27320173
    [Abstract] [Full Text] [Related]

  • 15. Influence of triglyceride concentration on the relationship between lipoprotein cholesterol and apolipoprotein B and A-I levels.
    Leroux G, Lemieux I, Lamarche B, Cantin B, Dagenais GR, Lupien PJ, Després JP.
    Metabolism; 2000 Jan 08; 49(1):53-61. PubMed ID: 10647064
    [Abstract] [Full Text] [Related]

  • 16. Doxazosin reduces prevalence of small dense low density lipoprotein and remnant-like particle cholesterol levels in nondiabetic and diabetic hypertensive patients.
    Hirano T, Yoshino G, Kashiwazaki K, Adachi M.
    Am J Hypertens; 2001 Sep 08; 14(9 Pt 1):908-13. PubMed ID: 11587157
    [Abstract] [Full Text] [Related]

  • 17. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M, Egger P, Soudant C, Le Goff W, van Tol A, Dupuis R, Chapman MJ.
    Atherosclerosis; 2002 Aug 08; 163(2):287-96. PubMed ID: 12052475
    [Abstract] [Full Text] [Related]

  • 18. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia.
    Brunzell JD, Albers JJ, Chait A, Grundy SM, Groszek E, McDonald GB.
    J Lipid Res; 1983 Feb 08; 24(2):147-55. PubMed ID: 6403642
    [Abstract] [Full Text] [Related]

  • 19. High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN): an interventional study.
    Wojczynski MK, Glasser SP, Oberman A, Kabagambe EK, Hopkins PN, Tsai MY, Straka RJ, Ordovas JM, Arnett DK.
    Lipids Health Dis; 2011 Oct 18; 10():181. PubMed ID: 22008512
    [Abstract] [Full Text] [Related]

  • 20. Effects of fluvastatin slow-release (XL 80 mg) versus simvastatin (20 mg) on the lipid triad in patients with type 2 diabetes.
    Bevilacqua M, Righini V, Barrella M, Vago T, Chebat E, Dominguez LJ.
    Adv Ther; 2005 Oct 18; 22(6):527-42. PubMed ID: 16510370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.